tirzepatide patient information leaflet Heart Rate Increase: Evidence and Monitoring Guidance Tirzepatide Dosage Guidelines and Chart

I have lost down from 250-165 over 2 years Rated 5 out of 5 Diane (verified owner) Verified review - view original Great product, great company to work with

This is also why we do not treat your first medication choice as permanent

Patients in the clinical trials, who all have diabetes and/or obesity, also had fewer complaints about nausea and diarrhea

Bottom line Its up to you and your provider to decide how long you should stay on GLP-1 medications, and at what dose, to achieve and maintain sustainable weight loss

Diabetic retinopathy complications have been observed primarily with semaglutide, particularly with rapid glucose improvement in patients with pre-existing retinopathy, warranting ophthalmologic monitoring in high-risk individuals